Cargando…
New Frontiers: ARID3a in SLE
Systemic lupus erythematosus (SLE) is a devastating and heterogeneous autoimmune disease that affects multiple organs, and for which the underlying causes are unknown. The majority of SLE patients produce autoantibodies, have increased levels of type-I inflammatory cytokines, and can develop glomeru...
Autores principales: | Garton, Joshua, Barron, M. David, Ratliff, Michelle L., Webb, Carol F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830313/ https://www.ncbi.nlm.nih.gov/pubmed/31554207 http://dx.doi.org/10.3390/cells8101136 |
Ejemplares similares
-
ARID3a expression in human hematopoietic stem cells is associated with distinct gene patterns in aged individuals
por: Ratliff, Michelle L., et al.
Publicado: (2020) -
Expression and methylation data from SLE patient and healthy control blood samples subdivided with respect to ARID3a levels
por: Ward, Julie M., et al.
Publicado: (2016) -
The Bright Side of Hematopoiesis: Regulatory Roles of ARID3a/Bright in Human and Mouse Hematopoiesis
por: Ratliff, Michelle L., et al.
Publicado: (2014) -
TLR engagement induces ARID3a in human blood hematopoietic progenitors and modulates IFNα production
por: Ratliff, Michelle L., et al.
Publicado: (2020) -
Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
por: Basta, Fabio, et al.
Publicado: (2020)